Biosimilars

COVID-19

Cataract Surgery

Cataract

Cataract Therapeutics

Clinical Diagnosis

Cornea

Dry Eye Awareness

Dry Eye

Gene Therapy

Geographic Atrophy

Glaucoma Awareness

Glaucoma Insights

Therapeutic Glaucoma

Glaucoma

IOL Advances

Imaging

Ocular Allergy

Ocular Surface Disease

Optic Relief

Optometry

Pediatrics

Pharmacy

Indispensable

Practice Management

Presbyopia

Ptosis

Refractive Surgery

Refractive

Retina

Surgery

Technology

Therapeutics

Understanding Antibiotic Resistance

Workplace

News

All News

Contributors

Money Matters

Media

Expert Interviews

Medical World News

Podcasts

Case Based Roundtable Series

Case of the Quarter

EyeView

Grand Rounds

Insights

Rapid Readout

Viewpoints

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Events

Publications

Digital Edition

Europe Ophthalmology Times

Modern Retina

Supplements and Featured Publications

Partners

Subscribe

Resources

Job Board

About

Advertise

Privacy

Editorial

Terms and Conditions

Contact Us

Do Not Sell My Personal Information

Ophthalmology Times - Ophthalmology news, articles, and events

Facebook

Twitter

Instagram

LinkedIn

Spotlight

Clinical

View

Modern Approaches for Optimal Management of Dry Eye Disease

Videos

Experts discuss the prevalence of dry eye disease (DED), their diagnostic and therapeutic approaches, as well as new FDA-approved and emerging treatments for DED.

Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss the prevalence of dry eye disease (DED) and how it can impact the quality of life for patients. 

The Prevalence and Impact of Dry Eye Disease

Experts discuss the impact of dry eye disease (DED) on coexisting ocular conditions and their clinical experience managing these patients. 

The Impact of Dry Eye Disease on Coexisting Ocular Conditions 

Experts offer their clinical perspectives on the use of dry eye questionnaires as a method of screening for dry eye disease (DED). 

Clinical Perspectives on Standard Use of Dry Eye Disease Questionnaire

Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss their preferred clinical diagnostic tools and tests to evaluate patients for dry eye disease (DED) and strategies for educating patients on their results. 

Diagnostic Tests for Dry Eye Disease

Experts discuss various treatment approaches for patients with dry eye disease (DED). They also highlight the challenges and drawbacks of using artificial tears to treat DED.

Dry Eye Treatment Approaches and the Use of Artificial Tears

Kelly K. Nichols, OD, MPH, PhD, discusses various anti-inflammatory treatment options for dry eye disease (DED), such as cyclosporine, lifitegrast, and varenicline. In addition, Cynthia Matossian, MD, FACS, provides an overview of the mechanism of action of lifitegrast and how it differs from cyclosporine. 

Anti-Inflammatory Therapies for Dry Eye Disease

Experts discuss key factors to consider when using anti-inflammatory agents to treat dry eye disease (DED). 

Factors to Consider in Choosing Anti-Inflammatory Therapies for Dry Eye Disease 

Kelly K. Nichols, OD, MPH, PhD, and Crystal Brimer, OD, provide their clinical advice on managing patients with overlapping eye diseases that need surgical treatment.

Managing Patients With Dry Eye Disease Pre-Cataract or Refractive Surgery

Cynthia Matossian, MD, FACS, provides her clinical advice on developing a treatment algorithm for patients with dry eye disease (DED). 

Developing Treatment Algorithm for Dry Eye Disease. 

Experts offer their clinical expertise on managing patients with dry eye disease (DED) with concurrent procedural and pharmacological therapies and the importance of individualized care. 

Combining Procedural and Pharmacological Therapies in Dry Eye Disease

Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss three new FDA-approved therapies for the treatment of dry eye disease (DED). 

New FDA-Approved Therapies and Diagnostics for Dry Eye Disease

Crystal Brimer, OD, and Kelly K. Nichols, OD, MPH, PhD, discuss two treatments, AZR-MD-001 and Reproxalap, that are in the pipeline to treat patients with dry eye disease (DED).

Emerging Therapies for Dry Eye Disease

Experts discuss their clinical approaches for co-managing patients with dry eye disease and how they educate patients and their providers about the disease. 

Co-Management of Dry Eye Disease 

Experts conclude their discussion sharing clinical peals on the management of dry eye disease (DED) and how providers may invest in their practice to better screen and treat their patients. 

Clinical Pearls for Management of Dry Eye Disease

The Ophthalmology Times® Viewpoints program facilitates roundtable discussions with experts of the ophthalmic community to explore a variety of disease focused topics. Areas of discussion include diagnosis & treatment, patient journey, treatment planning, treatment options, and genetic testing.

Emerging Therapies for Dry Eye Disease

EP: 1.The Prevalence and Impact of Dry Eye Disease

EP: 2.The Impact of Dry Eye Disease on Coexisting Ocular Conditions

EP: 3.Clinical Perspectives on Standard Use of Dry Eye Disease Questionnaire

EP: 4.Diagnostic Tests for Dry Eye Disease

EP: 5.Dry Eye Treatment Approaches and the Use of Artificial Tears

EP: 6.Anti-Inflammatory Therapies for Dry Eye Disease

EP: 7.Factors to Consider in Choosing Anti-Inflammatory Therapies for Dry Eye Disease

EP: 8.Managing Patients With Dry Eye Disease Pre-Cataract or Refractive Surgery

EP: 9.Developing Treatment Algorithm for Dry Eye Disease.

EP: 10.Combining Procedural and Pharmacological Therapies in Dry Eye Disease

EP: 11.New FDA-Approved Therapies and Diagnostics for Dry Eye Disease

EP: 12.Emerging Therapies for Dry Eye Disease

EP: 13.Co-Management of Dry Eye Disease

EP: 14.Clinical Pearls for Management of Dry Eye Disease